Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 3, Pages 1353
Publisher
MDPI AG
Online
2022-01-26
DOI
10.3390/ijms23031353
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long Noncoding RNA LINC-PINT Suppresses Cell Proliferation, Invasion, and EMT by Blocking Wnt/β-Catenin Signaling in Glioblastoma
- (2021) Hanshuo Zhu et al. Frontiers in Pharmacology
- Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
- (2021) Mehdi Eshraghi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update
- (2021) Mayra Colardo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Is There an Interconnection between Epithelial–Mesenchymal Transition (EMT) and Telomere Shortening in Aging?
- (2021) Siti A. M. Imran et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lactate Reprograms Energy and Lipid Metabolism in Glucose-Deprived Oxidative Glioma Stem Cells
- (2021) Noriaki Minami et al. Metabolites
- Autophagy and cancer metastasis: a Trojan horse
- (2021) Javad Alizadeh et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
- (2021) Wei Wu et al. PHARMACOLOGICAL RESEARCH
- Cell tracing reveals the transdifferentiation fate of mouse lung epithelial cells during pulmonary fibrosis in vivo
- (2021) Wei Tan et al. Experimental and Therapeutic Medicine
- MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism
- (2020) JianXing Yin et al. Cancer Cell International
- Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway
- (2020) Yingjun Zhu et al. Frontiers in Pharmacology
- Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma
- (2020) Bhavesh K. Ahir et al. MOLECULAR NEUROBIOLOGY
- Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma
- (2020) Yetirajam Rajesh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment
- (2020) Shiva Kant et al. Cell Death & Disease
- Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours
- (2020) Fei Xu et al. Cell and Bioscience
- MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT
- (2020) Chengbin Zhao et al. Scientific Reports
- Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma
- (2020) Eun-Jin Yun et al. Cell Death & Disease
- Autophagy and the Wnt signaling pathway: A focus on Wnt/β-catenin signaling
- (2020) Shahrokh Lorzadeh et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- EMT Regulation by Autophagy: A New Perspective in Glioblastoma Biology
- (2019) Barbara Colella et al. Cancers
- Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
- (2019) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival
- (2019) Georgios Batsios et al. Scientific Reports
- LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition
- (2019) Chuanhong Zhong et al. BIOMEDICINE & PHARMACOTHERAPY
- Simvastatin Increases Temozolomide‐induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes
- (2019) Shahla Shojaei et al. FEBS Journal
- Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models
- (2019) Caroline Von Achenbach et al. JOURNAL OF NEUROCHEMISTRY
- Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
- (2019) Karen G. de la Cruz-López et al. Frontiers in Oncology
- Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2
- (2019) Haiyang Xu et al. Stem Cell Research & Therapy
- Long noncoding RNA SNHG7 promotes the progression and growth of glioblastoma via inhibition of miR-5095
- (2018) Jie Ren et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Autophagy modulates transforming growth factor beta 1 induced epithelial to mesenchymal transition in non-small cell lung cancer cells
- (2018) Javad Alizadeh et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells
- (2018) Catherine J. Libby et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Repurposing drugs for glioblastoma: From bench to bedside
- (2018) João Basso et al. CANCER LETTERS
- EGFRvIII–Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival
- (2018) Alison Roos et al. MOLECULAR CANCER RESEARCH
- Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
- (2018) Sabine Hombach-Klonisch et al. PHARMACOLOGY & THERAPEUTICS
- Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro
- (2018) Abigail Kora Suwala et al. Oncotarget
- The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor
- (2018) Mariachiara Zuccarini et al. Genes
- mTOR Cross-Talk in Cancer and Potential for Combination Therapy
- (2018) Fabiana Conciatori et al. Cancers
- Regulation and modulation of PTEN activity
- (2018) Elahe Naderali et al. MOLECULAR BIOLOGY REPORTS
- Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities
- (2018) Sherri Z. Millis et al. CANCER
- Autophagy induction impairs Wnt/β-catenin signalling through β-catenin relocalisation in glioblastoma cells
- (2018) Barbara Colella et al. CELLULAR SIGNALLING
- Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence
- (2018) Carmen Mecca et al. DISEASE MARKERS
- Statins: a new approach to combat temozolomide chemoresistance in glioblastoma
- (2018) Shahla Shojaei et al. JOURNAL OF INVESTIGATIVE MEDICINE
- MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44
- (2018) Ling Li et al. JOURNAL OF NEURO-ONCOLOGY
- Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway
- (2017) Wei Chen et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab
- (2017) Victor A. Levin et al. JOURNAL OF NEURO-ONCOLOGY
- Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
- (2017) Hua-fu Zhao et al. Molecular Cancer
- Targeting WNT Signaling for Multifaceted Glioblastoma Therapy
- (2017) Matthew McCord et al. Frontiers in Cellular Neuroscience
- Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma
- (2017) Takuya Furuta et al. Oncotarget
- Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma
- (2017) Yun Wang et al. Oncotarget
- Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit
- (2017) Claudia R. Oliva et al. Oncotarget
- Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway
- (2017) Wei Zhou et al. Frontiers in Molecular Neuroscience
- Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma
- (2017) Alexandre Vallée et al. Frontiers in Physiology
- The effects of PI3K-mediated signalling on glioblastoma cell behaviour
- (2017) Julia Langhans et al. Oncogenesis
- Suppression of autophagy impedes glioblastoma development and induces senescence
- (2016) Noor Gammoh et al. Autophagy
- Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress
- (2016) Yingying Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma
- (2016) Marianne Labussière et al. CANCER INVESTIGATION
- Acidosis Drives the Reprogramming of Fatty Acid Metabolism in Cancer Cells through Changes in Mitochondrial and Histone Acetylation
- (2016) Cyril Corbet et al. Cell Metabolism
- Discovery and SAR of Novel 2,3-Dihydroimidazo[1,2-c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80-6946)
- (2016) William J. Scott et al. ChemMedChem
- Role of mTOR in glioblastoma
- (2016) Zekeriya Duzgun et al. GENE
- Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance
- (2016) Ahmed M. Hegazy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition
- (2016) Hua-Fu Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma
- (2016) Emeline Tabouret et al. JOURNAL OF NEURO-ONCOLOGY
- Quinacrine Mediated Sensitization of Glioblastoma (GBM) Cells to TRAIL through MMP-Sensitive PEG Hydrogel Carriers
- (2016) Pelin Erkoc et al. MACROMOLECULAR BIOSCIENCE
- Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin
- (2016) Eui Hyun Kim et al. NEURO-ONCOLOGY
- Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells
- (2016) Hua Lin et al. NEURO-ONCOLOGY
- AMPK promotes tolerance to Ras pathway inhibition by activating autophagy
- (2016) S Sanduja et al. ONCOGENE
- Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?
- (2016) Chiara Cilibrasi et al. PPAR Research
- Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR
- (2016) Timothy P. Heffron et al. ACS Medicinal Chemistry Letters
- Epithelial-mesenchymal transition in glioblastoma progression
- (2016) YASUO IWADATE Oncology Letters
- Histopathological investigation of glioblastomas resected under bevacizumab treatment
- (2016) Ryota Tamura et al. Oncotarget
- PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression
- (2016) Grazia Maugeri et al. Frontiers in Pharmacology
- Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization
- (2016) Keiichiro Hayashi et al. Scientific Reports
- miR-590-3p suppresses cancer cell migration, invasion and epithelial–mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2
- (2015) Hengyuan Pang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic Benefit
- (2015) Ksenya Shchors et al. CANCER CELL
- NVP-BEZ235, a novel dual PI3K–mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells
- (2015) Zhiyun Yu et al. CANCER LETTERS
- Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells
- (2015) C. Venugopal et al. CLINICAL CANCER RESEARCH
- Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma
- (2015) E. Januel et al. EUROPEAN JOURNAL OF NEUROLOGY
- Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-beta
- (2015) Laurent-Olivier Roy et al. INVESTIGATIONAL NEW DRUGS
- Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment
- (2015) Kazuhiro Tanaka et al. JOURNAL OF CLINICAL INVESTIGATION
- Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells
- (2015) Richard E. Kast et al. JOURNAL OF NEURO-ONCOLOGY
- Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed
- (2015) Yuliana Yosaatmadja et al. JOURNAL OF STRUCTURAL BIOLOGY
- The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models
- (2015) P. Foster et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Wnts at the Source--New Mechanisms, New Biomarkers, New Drugs
- (2015) B. Madan et al. MOLECULAR CANCER THERAPEUTICS
- EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling
- (2015) Feng Liu et al. MOLECULAR CELL
- Autophagy induction impairs migration and invasion by reversing EMT in glioblastoma cells
- (2015) Myriam Catalano et al. Molecular Oncology
- Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
- (2015) Lin Zhang et al. NATURE
- Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma
- (2015) Saverio Tardito et al. NATURE CELL BIOLOGY
- Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
- (2015) Kenneth S Thress et al. NATURE MEDICINE
- Phase II study of PX-866 in recurrent glioblastoma
- (2015) M. W. Pitz et al. NEURO-ONCOLOGY
- Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma
- (2015) Ulrik Lassen et al. NEURO-ONCOLOGY
- Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors
- (2015) Encouse B. Golden et al. Neurosurgical Focus
- Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism
- (2015) Krzysztof Piotr Michalak et al. Oxidative Medicine and Cellular Longevity
- MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway
- (2015) Liang Shen et al. TUMOR BIOLOGY
- The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor
- (2015) Huey-En Tzeng et al. Oncotarget
- Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma
- (2015) Tobias Kessler et al. Oncotarget
- Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo
- (2015) Zhiyun Yu et al. Oncotarget
- Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells
- (2015) Simona Daniele et al. Scientific Reports
- Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response
- (2015) Julie Sesen et al. PLoS One
- Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
- (2015) Jennifer M. Atkinson et al. PLoS One
- The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma
- (2015) Fabiana Salm et al. PLoS One
- The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma Model
- (2015) Eric C. Woolf et al. PLoS One
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
- (2015) James Andrew McCubrey et al. Oncotarget
- Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current
- (2015) Marta Gritti et al. Oncotarget
- Itraconazole suppresses the growth of glioblastoma through induction of autophagy
- (2014) Rui Liu et al. Autophagy
- Angiogenic factors as potential drug target: Efficacy and limitations of anti-angiogenic therapy
- (2014) Rajesh N. Gacche et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases
- (2014) Eun Jung Choi et al. BMC CANCER
- In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells
- (2014) P Jiang et al. BRITISH JOURNAL OF CANCER
- Regulation of dimethyl-fumarate toxicity by proteasome inhibitors
- (2014) Laurence Booth et al. CANCER BIOLOGY & THERAPY
- Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases
- (2014) Tomoyuki Mashimo et al. CELL
- The Somatic Genomic Landscape of Glioblastoma
- (2014) Cameron W. Brennan et al. CELL
- Antiangiogenic Therapy for Glioblastoma: Current Status and Future Prospects
- (2014) T. T. Batchelor et al. CLINICAL CANCER RESEARCH
- Autophagy Is a Survival Mechanism of Acute Myelogenous Leukemia Precursors during Dual mTORC2/mTORC1 Targeting
- (2014) J. K. Altman et al. CLINICAL CANCER RESEARCH
- Autophagy contributes to gefitinib-induced glioma cell growth inhibition
- (2014) Cheng-Yi Chang et al. EXPERIMENTAL CELL RESEARCH
- ERGO: A pilot study of ketogenic diet in recurrent glioblastoma
- (2014) JOHANNES RIEGER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cucurbitacin I Induces Protective Autophagy in Glioblastomain Vitroandin Vivo
- (2014) Guang Yuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery and in Vivo Evaluation of (S)-N-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease
- (2014) Timothy D. Cushing et al. JOURNAL OF MEDICINAL CHEMISTRY
- Glucose-6–phosphatase Is a Key Metabolic Regulator of Glioblastoma Invasion
- (2014) Sara Abbadi et al. MOLECULAR CANCER RESEARCH
- Characterization of the Activity of the PI3K/mTOR Inhibitor XL765 (SAR245409) in Tumor Models with Diverse Genetic Alterations Affecting the PI3K Pathway
- (2014) P. Yu et al. MOLECULAR CANCER THERAPEUTICS
- Hexokinase-II Positively Regulates Glucose Starvation-Induced Autophagy through TORC1 Inhibition
- (2014) David J. Roberts et al. MOLECULAR CELL
- MicroRNA-16 suppresses epithelial-mesenchymal transition-related gene expression in human glioma
- (2014) QIN WANG et al. Molecular Medicine Reports
- Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor
- (2014) Dejan Juric et al. NATURE
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1α
- (2014) MIN HUANG et al. ONCOLOGY REPORTS
- mTORC2 in the center of cancer metabolic reprogramming
- (2014) Kenta Masui et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial
- (2014) Shingo Takano et al. OncoTargets and Therapy
- FGF10: Type III Epithelial Mesenchymal Transition and Invasion in Breast Cancer Cell Lines
- (2014) Ali Abolhassani et al. Journal of Cancer
- Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways
- (2014) Sachin S. Rathod et al. FEBS Open Bio
- Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation
- (2013) Pascal Furet et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc
- (2013) Kenta Masui et al. Cell Metabolism
- The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas
- (2013) B. Gini et al. CLINICAL CANCER RESEARCH
- Autolysosomal β-catenin degradation regulates Wnt-autophagy-p62 crosstalk
- (2013) Katy J Petherick et al. EMBO JOURNAL
- The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
- (2013) Florian A. Siebzehnrubl et al. EMBO Molecular Medicine
- mTORC2 phosphorylates protein kinase Cζ to regulate its stability and activity
- (2013) Xin Li et al. EMBO REPORTS
- Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474)
- (2013) LEHANG LIN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Loss of Tsc1 accelerates malignant gliomagenesis when combined with oncogenic signals
- (2013) Daisuke Yamada et al. JOURNAL OF BIOCHEMISTRY
- Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology
- (2013) Venus Thomanetz et al. JOURNAL OF CELL BIOLOGY
- Up-regulation of USP2a and FASN in gliomas correlates strongly with glioma grade
- (2013) Bang-Bao Tao et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Discovery of 2-{3-[2-(1-Isopropyl-3-methyl-1H-1,2–4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamide (GDC-0032): A β-Sparing Phosphoinositide 3-Kinase Inhibitor with High Unbound Exposure and Robust in Vivo Antitumor Activity
- (2013) Chudi O. Ndubaku et al. JOURNAL OF MEDICINAL CHEMISTRY
- BAY 80-6946 Is a Highly Selective Intravenous PI3K Inhibitor with Potent p110α and p110δ Activities in Tumor Cell Lines and Xenograft Models
- (2013) Ningshu Liu et al. MOLECULAR CANCER THERAPEUTICS
- Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
- (2013) Luc G T Morris et al. NATURE GENETICS
- Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis
- (2013) M. Vitucci et al. NEURO-ONCOLOGY
- Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target
- (2013) Marianne Hütt-Cabezas et al. NEURO-ONCOLOGY
- The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells
- (2013) Jenna Kahn et al. NEURO-ONCOLOGY
- Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma
- (2013) Roshan Mahabir et al. NEURO-ONCOLOGY
- Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
- (2013) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2013) B. E. Johnson et al. SCIENCE
- Cellular Plasticity Confers Migratory and Invasive Advantages to a Population of Glioblastoma-Initiating Cells that Infiltrate Peritumoral Tissue
- (2013) Patricia Ruiz-Ontañon et al. STEM CELLS
- IBP-mediated suppression of autophagy promotes growth and metastasis of breast cancer cells via activating mTORC2/Akt/FOXO3a signaling pathway
- (2013) S Chen et al. Cell Death & Disease
- Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells
- (2013) Lakshmipathi Vadlakonda et al. Frontiers in Oncology
- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
- (2012) Kan V. Lu et al. CANCER CELL
- Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition
- (2012) Ulf D. Kahlert et al. CANCER LETTERS
- Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas
- (2012) U.D. Kahlert et al. CANCER LETTERS
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
- (2012) Ester Sánchez-Tilló et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets
- (2012) Janice A. Nagy et al. CLINICAL & EXPERIMENTAL METASTASIS
- c-Myc and Cancer Metabolism
- (2012) D. M. Miller et al. CLINICAL CANCER RESEARCH
- Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients
- (2012) A. F. Carpentier et al. EUROPEAN JOURNAL OF NEUROLOGY
- Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function
- (2012) Lomon So et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Salinomycin as a Drug for Targeting Human Cancer Stem Cells
- (2012) Cord Naujokat et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511
- (2012) Mark H. Norman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model
- (2012) Stephen T. Keir et al. JOURNAL OF NEURO-ONCOLOGY
- Human target validation of phosphoinositide 3-kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor
- (2012) S. NYLANDER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- VS-5584, a Novel and Highly Selective PI3K/mTOR Kinase Inhibitor for the Treatment of Cancer
- (2012) S. Hart et al. MOLECULAR CANCER THERAPEUTICS
- PRR5L degradation promotes mTORC2-mediated PKC-δ phosphorylation and cell migration downstream of Gα12
- (2012) Xiaoqing Gan et al. NATURE CELL BIOLOGY
- Metabolism of [U-13C]glucose in human brain tumorsin vivo
- (2012) Elizabeth A. Maher et al. NMR IN BIOMEDICINE
- Particle-in-cell simulations of beam-driven electrostatic waves in a plasma
- (2012) Etienne J. Koen et al. PHYSICS OF PLASMAS
- A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma
- (2012) Wei-Yi Cheng et al. PLoS One
- ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma
- (2012) Songtao Qi et al. PLoS One
- Minocycline inhibits the growth of glioma by inducing autophagy
- (2011) Wei-Ting Liu et al. Autophagy
- The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells
- (2011) Seung-Hyun Jeon et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799
- (2011) Jun Ohwada et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antitumor Activity of NVP-BKM120--A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells
- (2011) D. Koul et al. CLINICAL CANCER RESEARCH
- The Phosphoinositide 3-Kinase Signaling Pathway as a Therapeutic Target in Grade IV Brain Tumors
- (2011) K. Holand et al. CURRENT CANCER DRUG TARGETS
- The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion
- (2011) Sze Ki Luk et al. EUROPEAN JOURNAL OF CANCER
- Statin-induced apoptosis via the suppression of ERK1/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma
- (2011) Masashi Yanae et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer
- (2011) Daniel P. Sutherlin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Peroxisome proliferator-activated receptor γ agonist pioglitazone inhibits β-catenin-mediated glioma cell growth and invasion
- (2011) Zhengqiang Wan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor
- (2011) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- PF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor Activity
- (2011) J. Yuan et al. MOLECULAR CANCER THERAPEUTICS
- Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
- (2011) Olivier Keunen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer
- (2011) Matthew T. Burger et al. ACS Medicinal Chemistry Letters
- Oncogenic EGFR Signaling Activates an mTORC2-NF- B Pathway That Promotes Chemotherapy Resistance
- (2011) K. Tanaka et al. Cancer Discovery
- PI3K and STAT3: A New Alliance
- (2011) P. K. Vogt et al. Cancer Discovery
- CAL-101, a p110 selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
- (2010) B. J. Lannutti et al. BLOOD
- Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations
- (2010) Ce Liu et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Chlorpromazine activates p21Waf1/Cip1gene transcription via early growth response-1 (Egr-1) in C6 glioma cells
- (2010) Soon Young Shin et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma
- (2010) Ho-Shin Gwak et al. INTERNATIONAL JOURNAL OF CANCER
- Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
- (2010) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound26(PKI-587), a Highly Efficacious Dual Inhibitor
- (2010) Aranapakam M. Venkatesan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hypoxia-inducible factor 1α expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image
- (2010) Ryota Mashiko et al. JOURNAL OF NEURO-ONCOLOGY
- TWIST1 promotes invasion through mesenchymal change in human glioblastoma
- (2010) Svetlana A Mikheeva et al. Molecular Cancer
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma
- (2010) D. Koul et al. NEURO-ONCOLOGY
- mTOR signaling in glioblastoma: lessons learned from bench to bedside
- (2010) D. Akhavan et al. NEURO-ONCOLOGY
- Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
- (2010) Steven D. Knight et al. ACS Medicinal Chemistry Letters
- Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility
- (2009) Jhanwar-Uniyal INTERNATIONAL JOURNAL OF ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- The Alkylphospholipid Perifosine Induces Apoptosis and p21-Mediated Cell Cycle Arrest in Medulloblastoma
- (2009) A. Kumar et al. MOLECULAR CANCER RESEARCH
- Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
- (2009) G. L. Gallia et al. MOLECULAR CANCER THERAPEUTICS
- Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941
- (2009) F. I. Raynaud et al. MOLECULAR CANCER THERAPEUTICS
- EGF-Induced ERK Activation Promotes CK2-Mediated Disassociation of α-Catenin from β-Catenin and Transactivation of β-Catenin
- (2009) Haitao Ji et al. MOLECULAR CELL
- EFFECT OF SIMVASTATIN ON GLIOMA CELL PROLIFERATION, MIGRATION, AND APOPTOSIS
- (2009) Hongtao Wu et al. NEUROSURGERY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- PI3K Signaling in Glioma-Animal Models and Therapeutic Challenges
- (2008) Christine K. Cheng et al. BRAIN PATHOLOGY
- Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme
- (2008) Jeannette R. Flynn et al. CANCER
- The Protein Phosphatase Activity of PTEN Regulates Src Family Kinases and Controls Glioma Migration
- (2008) N. Dey et al. CANCER RESEARCH
- Targeting the PI3K p110 Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration
- (2008) A. S. Guerreiro et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†
- (2008) Adrian J. Folkes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
- Direct regulation of TWIST by HIF-1α promotes metastasis
- (2008) Muh-Hwa Yang et al. NATURE CELL BIOLOGY
- Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3
- (2008) Michal O. Nowicki et al. NEURO-ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started